InterWest Partners

InterWest Partners, founded in 1979 and based in San Francisco, California, is a venture capital firm that specializes in investing in the information technology and healthcare sectors. The firm typically invests between $7 million and $15 million in each portfolio company, engaging through various stages of venture investment, primarily focusing on early-stage companies. InterWest aims to identify and pursue attractive investment opportunities based on their individual merits, rather than strictly adhering to a specific investment stage. The firm is dedicated to supporting emerging life sciences and information technology ventures, with plans to invest in approximately 25 to 30 new companies within each sector, while also considering select later-stage opportunities.

Keval Desai

General Partner

Khaled Nasr

General Partner and COO

Karen Wilson

CFO

Reza Zadno

Venture Partner

427 past transactions

GoCheck

Venture Round in 2021
GoCheck, formerly known as Gobiquity, Inc., is a technology company based in Aliso Viejo, California, that specializes in mobile health applications aimed at the early detection and prevention of eye diseases in children. The company's flagship product, GoCheck Kids, is a smartphone app designed for the screening of amblyopia risk factors, adhering to guidelines established by the American Association for Pediatric Ophthalmology and Strabismus. With a focus on affordability, GoCheck Kids reduces the cost of vision screening by over 60% by utilizing the manufacturing capabilities of smartphones. The app is FDA-registered and CE certified, and it is currently utilized by over 6,500 pediatric teams across the U.S. and Europe. By facilitating early detection, GoCheck aims to combat vision impairment, a leading disabling condition among children, which can severely impact learning and overall health outcomes.

PMV Pharmaceuticals

Series C in 2019
PMV Pharmaceuticals, Inc. is a precision oncology company focused on the discovery and development of small molecule therapies targeting p53 mutations in cancer. Its lead candidate, PC14586, aims to correct and restore the function of the p53 protein, which is critical in regulating cell growth and preventing tumor formation. In addition to PC14586, the company is developing therapies for various p53 hotspot mutations, including the R273H mutation. Founded in 2013 and headquartered in Cranbury, New Jersey, PMV Pharmaceuticals leverages extensive expertise in p53 biology to advance its innovative treatment options for cancer patients.

Welcome

Venture Round in 2019
Welcome is a marketing orchestration platform designed to enhance the efficiency and effectiveness of marketing teams. As a brand under NewsCred, it focuses on transforming marketing operations by aligning teams and streamlining execution processes. Welcome caters to the complexities of modern marketing, providing a scalable solution that supports large teams and integrates with various marketing technology tools. It enables marketers to collaborate more effectively, manage campaigns and content seamlessly, and demonstrate measurable results. By offering a comprehensive platform, Welcome empowers brands to maximize their marketing potential and achieve their strategic goals.

Aryaka Networks

Series F in 2019
Aryaka Networks, Inc. is a provider of cloud-based networking and security solutions, headquartered in San Mateo, California, with additional offices in Dallas, Bengaluru, Beijing, Singapore, London, and Toronto. Founded in 2008, the company specializes in software-defined wide area network (SD-WAN) services, offering a platform that integrates various networking needs, including WAN optimization, application acceleration, and security functions. Aryaka's services include WAN Optimization as-a-Service, which facilitates global connectivity and application performance, and SmartACCESS, a clientless SD-WAN solution for remote access. The company's offerings cater to enterprises and service providers worldwide, enabling improved connectivity for branch offices and cloud applications. Aryaka is recognized for its ability to modernize and optimize networking environments, ensuring that organizations can efficiently access centralized applications and public web resources regardless of location.

GoCheck

Series B in 2019
GoCheck, formerly known as Gobiquity, Inc., is a technology company based in Aliso Viejo, California, that specializes in mobile health applications aimed at the early detection and prevention of eye diseases in children. The company's flagship product, GoCheck Kids, is a smartphone app designed for the screening of amblyopia risk factors, adhering to guidelines established by the American Association for Pediatric Ophthalmology and Strabismus. With a focus on affordability, GoCheck Kids reduces the cost of vision screening by over 60% by utilizing the manufacturing capabilities of smartphones. The app is FDA-registered and CE certified, and it is currently utilized by over 6,500 pediatric teams across the U.S. and Europe. By facilitating early detection, GoCheck aims to combat vision impairment, a leading disabling condition among children, which can severely impact learning and overall health outcomes.

Splice Machine

Venture Round in 2019
Splice Machine, Inc. is a data platform company based in San Francisco, California, that develops a hybrid relational database management system (RDBMS) designed to seamlessly integrate streaming, analytics, and transactions. This platform leverages Apache Hadoop and Apache Spark to execute both operational and analytical workloads, allowing for real-time updates and the development of scalable applications without the need for application rewrites. Splice Machine's RDBMS is particularly beneficial for industries requiring digital marketing, ETL acceleration, operational data lakes, and Internet of Things applications. Additionally, the company offers Livewire, an open-source operational AI platform aimed at enhancing industrial IoT use cases by providing alerts to plant operators regarding outages or performance issues. Founded in 2012, Splice Machine aims to disrupt the traditional database market by enabling clients to reduce latency, costs, and complexity associated with legacy systems.

Aria Systems

Private Equity Round in 2018
Aria Systems provides a cloud-based monetization platform designed to assist subscription and usage-based businesses in effectively managing their revenue streams. The company offers an agile billing system that enables enterprises to capitalize on customer-driven events, referred to as revenue moments. By facilitating active customer engagement and the rapid development of new products and services, Aria's comprehensive platform allows global brands to enter the market more quickly and diversify their offerings. The platform also includes on-demand billing software, marketing intelligence tools, and customer lifecycle management services tailored for software-as-a-service (SaaS) companies, game developers, and telecommunications providers. Through these capabilities, Aria Systems aims to support long-term business growth and enhance customer satisfaction, retention, and lifetime value.

The RealReal

Series G in 2018
The RealReal operates as the largest online marketplace for authenticated, resale luxury goods, specializing in various categories such as fashion for women, men, and children, as well as jewelry, watches, home items, and art. Founded in 2011 and headquartered in San Francisco, the company boasts over 37 million members and has sold nearly 40 million items through its platform. The RealReal employs a rigorous authentication process managed by in-house experts, including gemologists and horologists, ensuring the reliability of its offerings. As a sustainable business, it promotes the circular economy by giving new life to luxury items from numerous brands. The company simplifies the selling process for consignors with services such as virtual appointments, in-home pickups, and direct shipping, while managing all aspects of the transaction, from pricing and listing to shipping and customer service. In 2023, The RealReal generated significant gross merchandise volume, capitalizing on a market previously underserved by traditional retail outlets.

Aryaka Networks

Series E in 2018
Aryaka Networks, Inc. is a provider of cloud-based networking and security solutions, headquartered in San Mateo, California, with additional offices in Dallas, Bengaluru, Beijing, Singapore, London, and Toronto. Founded in 2008, the company specializes in software-defined wide area network (SD-WAN) services, offering a platform that integrates various networking needs, including WAN optimization, application acceleration, and security functions. Aryaka's services include WAN Optimization as-a-Service, which facilitates global connectivity and application performance, and SmartACCESS, a clientless SD-WAN solution for remote access. The company's offerings cater to enterprises and service providers worldwide, enabling improved connectivity for branch offices and cloud applications. Aryaka is recognized for its ability to modernize and optimize networking environments, ensuring that organizations can efficiently access centralized applications and public web resources regardless of location.

Avedro

Series F in 2018
Avedro, Inc. is a medical device and pharmaceutical company specializing in the treatment of corneal disorders, particularly corneal ectatic conditions and refractive errors. The company has developed the Avedro Corneal Remodeling platform, which includes the KXL and Mosaic systems that utilize ultraviolet A (UVA) light, alongside a range of single-use riboflavin drug formulations. These technologies are primarily aimed at treating progressive keratoconus and corneal ectasia following refractive surgery. Avedro also focuses on advancing the science of Thermo-biomechanics, exemplified by its Keraflex procedure, a non-invasive method for corneal reshaping that preserves the cornea's biomechanical integrity. The company's products are marketed to ophthalmologists, hospitals, and ambulatory surgery centers in the United States and through international distributors. Avedro, originally established as ThermalVision, Inc. in 2002, is headquartered in Waltham, Massachusetts, and operates as a subsidiary of Glaukos Corporation.

Totango

Series D in 2018
Totango, Inc. is a leading provider of a customer success platform designed to enhance customer engagement and drive business growth. Founded in 2010 and headquartered in Redwood City, California, the company specializes in customer-led growth by integrating customer data to monitor health changes and foster proactive engagement. Its suite of solutions includes the Customer Success Centre for customer engagement, Zoe for enterprise impact, and DNA-CX for real-time customer context. Additionally, Totango offers tools for customer onboarding, adoption, renewal, and risk management through its AI-powered Customer Intelligence Engine, Unison. The platform supports businesses in achieving predictable revenue and maximizing customer value by streamlining operations and providing actionable insights. Totango serves a diverse range of clients, including notable companies such as SAP and GitHub, and has established itself as an innovator in customer success technology. The organization has a remote workforce spanning multiple states and countries, with offices located in New York City and Tel Aviv.

Gynesonics

Private Equity Round in 2018
Gynesonics, Inc. is a medical device company that focuses on designing and developing minimally invasive solutions for symptomatic uterine fibroids in women. Established in 2005 and headquartered in Redwood City, California, with an additional location in Beuningen, the Netherlands, the company offers the Sonata System, which utilizes sonography-guided transcervical fibroid ablation for the treatment of fibroids under intrauterine sonography guidance. Gynesonics aims to provide a safe and effective incisionless alternative to traditional surgical techniques such as hysterectomy and myomectomy, thereby enabling women to receive painless treatments for severe menstrual symptoms associated with fibroids.

Centrexion Therapeutics

Series D in 2018
Centrexion Therapeutics Corporation is a late clinical-stage biopharmaceutical company based in Boston, Massachusetts, dedicated to developing non-opioid and non-addictive therapies aimed at addressing chronic pain. The company's product pipeline includes CNTX-4975, currently in Phase III trials for moderate to severe knee osteoarthritis pain, and in Phase II trials for Morton’s neuroma and canine osteoarthritis. Additionally, CNTX-0290 is in Phase I trials targeting chronic pain associated with inflammatory, neuropathic, and mixed conditions. Other candidates under development include CNTX-6970, for inflammatory pain, and CNTX-2022, a high-concentration topical gel formulation of lidocaine for various types of pain. CNTX-6016 is also in pre-clinical stages focusing on chronic neuropathic pain. Founded in 2013, Centrexion Therapeutics aims to provide safe and effective solutions for patients suffering from chronic pain conditions.

Splice Machine

Series B in 2017
Splice Machine, Inc. is a data platform company based in San Francisco, California, that develops a hybrid relational database management system (RDBMS) designed to seamlessly integrate streaming, analytics, and transactions. This platform leverages Apache Hadoop and Apache Spark to execute both operational and analytical workloads, allowing for real-time updates and the development of scalable applications without the need for application rewrites. Splice Machine's RDBMS is particularly beneficial for industries requiring digital marketing, ETL acceleration, operational data lakes, and Internet of Things applications. Additionally, the company offers Livewire, an open-source operational AI platform aimed at enhancing industrial IoT use cases by providing alerts to plant operators regarding outages or performance issues. Founded in 2012, Splice Machine aims to disrupt the traditional database market by enabling clients to reduce latency, costs, and complexity associated with legacy systems.

Achates Power

Series D in 2017
Achates Power, Inc. is a San Diego-based company that develops and manufactures internal combustion engines for various sectors, including commercial trucks, passenger vehicles, military, maritime, and stationary power industries. Founded in 2004, the company specializes in opposed-piston, two-stroke, and compression ignition engines that enhance fuel efficiency and reduce greenhouse gas emissions. Achates Power's innovative engine designs are compatible with existing fuel infrastructure, allowing manufacturers to meet stringent fuel efficiency and emissions standards without incurring significant additional costs or complexities. In addition to engine development, the company offers engineering services and technology licenses, providing clients with access to its designs, expertise, tools, control software, and patents.

Braze

Series D in 2017
Braze, Inc. is a customer engagement platform that specializes in enhancing interactions between consumers and brands across various industries, including retail, media, financial services, and hospitality. Founded in 2011 and headquartered in New York, Braze provides a suite of mobile marketing automation and customer relationship management solutions. The platform integrates tools for engagement orchestration, campaign optimization, and cross-channel personalization, utilizing an AI engine called Sage AI to enhance functionality. Braze enables brands to create meaningful, context-driven conversations through various channels, ensuring relevant and timely interactions. The company has additional offices in Chicago, London, San Francisco, and Singapore, reflecting its global presence and commitment to delivering exceptional customer experiences. Formerly known as Appboy, Braze rebranded in November 2017 to better align with its mission of fostering human connections between consumers and the brands they love.

Aria Systems

Series F in 2017
Aria Systems provides a cloud-based monetization platform designed to assist subscription and usage-based businesses in effectively managing their revenue streams. The company offers an agile billing system that enables enterprises to capitalize on customer-driven events, referred to as revenue moments. By facilitating active customer engagement and the rapid development of new products and services, Aria's comprehensive platform allows global brands to enter the market more quickly and diversify their offerings. The platform also includes on-demand billing software, marketing intelligence tools, and customer lifecycle management services tailored for software-as-a-service (SaaS) companies, game developers, and telecommunications providers. Through these capabilities, Aria Systems aims to support long-term business growth and enhance customer satisfaction, retention, and lifetime value.

Neuronetics

Series G in 2017
Neuronetics, Inc. is a commercial-stage medical technology company based in Malvern, Pennsylvania, focused on developing non-invasive therapies for psychiatric disorders. Founded in 2003, the company markets the NeuroStar Advanced Therapy System, which provides an innovative treatment for adult patients with major depressive disorder. This system employs transcranial magnetic stimulation, utilizing pulsed, MRI-strength magnetic fields to generate electrical currents that target specific brain areas linked to mood regulation. Neuronetics sells its products primarily through a dedicated sales and customer support team, catering to psychiatrists and healthcare providers. The company aims to enhance the quality of life for individuals suffering from mental health conditions through its advanced therapeutic solutions.

Avedro

Venture Round in 2017
Avedro, Inc. is a medical device and pharmaceutical company specializing in the treatment of corneal disorders, particularly corneal ectatic conditions and refractive errors. The company has developed the Avedro Corneal Remodeling platform, which includes the KXL and Mosaic systems that utilize ultraviolet A (UVA) light, alongside a range of single-use riboflavin drug formulations. These technologies are primarily aimed at treating progressive keratoconus and corneal ectasia following refractive surgery. Avedro also focuses on advancing the science of Thermo-biomechanics, exemplified by its Keraflex procedure, a non-invasive method for corneal reshaping that preserves the cornea's biomechanical integrity. The company's products are marketed to ophthalmologists, hospitals, and ambulatory surgery centers in the United States and through international distributors. Avedro, originally established as ThermalVision, Inc. in 2002, is headquartered in Waltham, Massachusetts, and operates as a subsidiary of Glaukos Corporation.

PMV Pharmaceuticals

Series B in 2017
PMV Pharmaceuticals, Inc. is a precision oncology company focused on the discovery and development of small molecule therapies targeting p53 mutations in cancer. Its lead candidate, PC14586, aims to correct and restore the function of the p53 protein, which is critical in regulating cell growth and preventing tumor formation. In addition to PC14586, the company is developing therapies for various p53 hotspot mutations, including the R273H mutation. Founded in 2013 and headquartered in Cranbury, New Jersey, PMV Pharmaceuticals leverages extensive expertise in p53 biology to advance its innovative treatment options for cancer patients.

Vidora

Seed Round in 2017
Vidora, Inc. is a technology company based in San Francisco, California, that specializes in machine learning solutions aimed at enhancing the performance of marketing and product teams. Founded in 2012, Vidora offers a platform called Cortex, which enables businesses to implement no-code machine learning for optimizing conversions and engagement. Cortex allows organizations to create numerous predictions that personalize customer experiences across various channels, including content and marketing, without the need for costly in-house development. Major global brands such as Walmart, News Corp, and Discovery utilize Vidora's platform to harness continuous data streams for improved performance and automation. Additionally, Vidora has established a strategic partnership with MoEngage to further its offerings.

Centrexion Therapeutics

Series C in 2016
Centrexion Therapeutics Corporation is a late clinical-stage biopharmaceutical company based in Boston, Massachusetts, dedicated to developing non-opioid and non-addictive therapies aimed at addressing chronic pain. The company's product pipeline includes CNTX-4975, currently in Phase III trials for moderate to severe knee osteoarthritis pain, and in Phase II trials for Morton’s neuroma and canine osteoarthritis. Additionally, CNTX-0290 is in Phase I trials targeting chronic pain associated with inflammatory, neuropathic, and mixed conditions. Other candidates under development include CNTX-6970, for inflammatory pain, and CNTX-2022, a high-concentration topical gel formulation of lidocaine for various types of pain. CNTX-6016 is also in pre-clinical stages focusing on chronic neuropathic pain. Founded in 2013, Centrexion Therapeutics aims to provide safe and effective solutions for patients suffering from chronic pain conditions.

Integrated Diagnostics

Series C in 2016
Integrated Diagnostics Inc. specializes in the development of laboratory-based blood molecular diagnostic tools designed to assist physicians in the early detection of complex diseases through non-invasive blood tests. The company's flagship product, Xpresys Lung, provides objective information for assessing pulmonary nodules by monitoring multiple disease molecular markers simultaneously. Founded in 2005 and based in Seattle, Washington, Integrated Diagnostics aims to leverage emerging technologies to create a pipeline of innovative diagnostic products that facilitate the management of serious conditions such as cancer, diabetes, and Alzheimer's. The company operates under the principle that a systems view of disease, involving networks of proteins, genes, and other molecules, is essential for effective diagnosis and prognosis. Integrated Diagnostics is a subsidiary of Biodesix, Inc. and has established a strategic partnership with Agilent Technologies.

Grokker

Series B in 2016
Grokker Inc. is an online fitness training platform that offers a wide range of expert-led video content focused on wellness, including fitness, cooking, yoga, mindfulness, nutrition, finance, and sleep. Founded in 2012 and based in San Jose, California, Grokker provides users with access to over 3,700 videos varying in length from 5 to 50 minutes. The platform is designed to support workplace wellness by delivering personalized and easily implementable programs that promote employee health and fitness. Users can explore diverse categories, such as yoga styles, fitness routines, and various cooking techniques, while benefiting from a community that fosters connection among employees. Grokker's model emphasizes convenience, allowing access to its resources anytime and from any device, helping clients maintain a consistent routine for improved well-being.

ReVision Optics

Venture Round in 2016
ReVision Optics, Inc. is a company based in Lake Forest, California, specializing in the design, manufacture, and delivery of implantable products aimed at treating presbyopia, a condition that affects near vision due to aging. The company offers the PRESBYLENS Corneal Inlay, a patented refractive surgery solution that enhances near vision for patients experiencing this common age-related vision loss. By providing innovative optical technology, ReVision Optics enables ophthalmology professionals to deliver improved eyesight solutions to their patients. Founded in 1996 and originally named IntraLens Vision, Inc., the company rebranded in 2005 to align with its focus on presbyopia treatments.

Cheetah Digital

Series A in 2016
Cheetah Digital is a cross-channel customer engagement solution provider for the modern marketer. Unlike walled garden marketing clouds and IT-centric CDPs, the Cheetah Digital Customer Engagement Suite enables marketers to drive revenue, build lasting customer relationships, and deliver a unique value exchange throughout the entire customer lifecycle. Enterprise brands can create personalized experiences, cross-channel messaging, and loyalty strategies, underpinned by our engagement data platform that can scale to meet the changing demands of today's consumer.

Welltok

Series E in 2016
Welltok is a data-driven enterprise SaaS company based in Denver, Colorado, founded in 2009. It specializes in providing a consumer activation platform that serves the healthcare industry. Welltok’s solutions enable health plans, employers, providers, and public entities to engage consumers with personalized health improvement resources. The platform leverages a vast consumer database and machine learning to facilitate targeted actions, making it easier and more rewarding for individuals to optimize their health and wellbeing. By driving audience engagement in healthy activities, Welltok helps organizations connect with consumers on a personal level, enhancing their overall health outcomes.

Totango

Series C in 2016
Totango, Inc. is a leading provider of a customer success platform designed to enhance customer engagement and drive business growth. Founded in 2010 and headquartered in Redwood City, California, the company specializes in customer-led growth by integrating customer data to monitor health changes and foster proactive engagement. Its suite of solutions includes the Customer Success Centre for customer engagement, Zoe for enterprise impact, and DNA-CX for real-time customer context. Additionally, Totango offers tools for customer onboarding, adoption, renewal, and risk management through its AI-powered Customer Intelligence Engine, Unison. The platform supports businesses in achieving predictable revenue and maximizing customer value by streamlining operations and providing actionable insights. Totango serves a diverse range of clients, including notable companies such as SAP and GitHub, and has established itself as an innovator in customer success technology. The organization has a remote workforce spanning multiple states and countries, with offices located in New York City and Tel Aviv.

Stellar Loyalty

Venture Round in 2016
Stellar Loyalty Inc. specializes in providing cloud-based customer loyalty and engagement solutions. Founded in 2014 and headquartered in Foster City, California, with additional offices in Manila, Philippines, Stellar Loyalty integrates mobile and big data technologies to enhance customer interactions. The company’s platform enables brands to recognize, engage, and reward loyal customers by connecting loyalty programs with point-of-sale, marketing, and customer relationship management systems. Their offerings include advanced features such as calculations, business rules, segmentations, and predictive analytics, which together facilitate a seamless experience across digital, physical, and human interactions. Stellar Loyalty aims to enhance consumer experiences by delivering personalized value and recognition to customers. The company was acquired by Cheetah Digital in 2018.

C3 AI

Series D in 2016
C3 AI (NYSE:AI) is a provider of Enterprise AI software for accelerating digital transformation. C3 AI delivers a family of fully integrated products: C3 AI® Suite, an end-to-end platform for developing, deploying, and operating large-scale AI applications; C3 AI Applications, a portfolio of industry-specific SaaS AI applications; C3 AI CRM, a suite of industry-specific CRM applications designed for AI and machine learning; and C3 AI Ex Machina, a no-code AI solution to apply data science to everyday business problems. The core of the C3 AI offering is an open, model-driven AI architecture that dramatically simplifies data science and application development. Learn more at: www.c3.ai

Restoration Robotics

Venture Round in 2016
Restoration Robotics is a privately held medical device company focused on advancing hair transplantation technology. It has developed the ARTAS™ System, an innovative image-guided platform that facilitates follicular unit extraction, enhancing the precision and efficiency of hair restoration procedures. By integrating advanced imaging and robotics, Restoration Robotics aims to improve outcomes for patients seeking hair transplants, positioning itself as a leader in the evolving field of hair restoration. The company is committed to transforming traditional practices through its state-of-the-art technology.

GoCheck

Series B in 2016
GoCheck, formerly known as Gobiquity, Inc., is a technology company based in Aliso Viejo, California, that specializes in mobile health applications aimed at the early detection and prevention of eye diseases in children. The company's flagship product, GoCheck Kids, is a smartphone app designed for the screening of amblyopia risk factors, adhering to guidelines established by the American Association for Pediatric Ophthalmology and Strabismus. With a focus on affordability, GoCheck Kids reduces the cost of vision screening by over 60% by utilizing the manufacturing capabilities of smartphones. The app is FDA-registered and CE certified, and it is currently utilized by over 6,500 pediatric teams across the U.S. and Europe. By facilitating early detection, GoCheck aims to combat vision impairment, a leading disabling condition among children, which can severely impact learning and overall health outcomes.

Wiser Solutions

Venture Round in 2016
Wiser Solutions is a leading provider of actionable data aimed at enhancing decision-making for brands and retailers. The company specializes in collecting and analyzing both online and in-store data with notable speed and precision. Its platform integrates insights from the retail sector with advanced workflow software, creating a comprehensive solution that serves various retail needs, including those of restaurants. By combining data science with human validation, Wiser offers a centralized approach to retail data analysis, enabling businesses to drive revenue, reduce costs, and improve marketing efficiency.

Khoros

Series F in 2016
Khoros is a software company specializing in customer engagement platforms. It offers a centralized cloud-based solution for social media management, enabling brands to monitor and scale their social marketing efforts and customer service interactions. The platform facilitates millions of conversations and drives informed decisions through data analysis, helping companies anticipate customer needs, accelerate sales, foster loyalty, and innovate by turning siloed knowledge into enterprise value and customers into contributors.

Khoros

Series F in 2016
Khoros is a software company specializing in customer engagement platforms. It offers a centralized cloud-based solution for social media management, enabling brands to monitor and scale their social marketing efforts and customer service interactions. The platform facilitates millions of conversations and drives informed decisions through data analysis, helping companies anticipate customer needs, accelerate sales, foster loyalty, and innovate by turning siloed knowledge into enterprise value and customers into contributors.

Braze

Series C in 2016
Braze, Inc. is a customer engagement platform that specializes in enhancing interactions between consumers and brands across various industries, including retail, media, financial services, and hospitality. Founded in 2011 and headquartered in New York, Braze provides a suite of mobile marketing automation and customer relationship management solutions. The platform integrates tools for engagement orchestration, campaign optimization, and cross-channel personalization, utilizing an AI engine called Sage AI to enhance functionality. Braze enables brands to create meaningful, context-driven conversations through various channels, ensuring relevant and timely interactions. The company has additional offices in Chicago, London, San Francisco, and Singapore, reflecting its global presence and commitment to delivering exceptional customer experiences. Formerly known as Appboy, Braze rebranded in November 2017 to better align with its mission of fostering human connections between consumers and the brands they love.

Obalon Therapeutics

Series E in 2016
Obalon Therapeutics, Inc. is a medical device company based in Carlsbad, California, that specializes in developing and commercializing innovative solutions for obesity treatment. The company is known for its Obalon Balloon System, which includes a swallowable capsule containing an inflatable balloon, a navigation console for tracking balloon placement, a semi-automated inflation device, and a disposable gas canister. This system aims to assist patients in achieving weight loss through a non-surgical approach. Founded in 2008, Obalon emphasizes collaboration with clinicians and a commitment to rigorous testing to ensure safety and performance in its products. As of early 2020, the company operated three retail treatment centers in California, reflecting its focus on providing accessible solutions for individuals struggling with obesity.

The RealReal

Series E in 2016
The RealReal operates as the largest online marketplace for authenticated, resale luxury goods, specializing in various categories such as fashion for women, men, and children, as well as jewelry, watches, home items, and art. Founded in 2011 and headquartered in San Francisco, the company boasts over 37 million members and has sold nearly 40 million items through its platform. The RealReal employs a rigorous authentication process managed by in-house experts, including gemologists and horologists, ensuring the reliability of its offerings. As a sustainable business, it promotes the circular economy by giving new life to luxury items from numerous brands. The company simplifies the selling process for consignors with services such as virtual appointments, in-home pickups, and direct shipping, while managing all aspects of the transaction, from pricing and listing to shipping and customer service. In 2023, The RealReal generated significant gross merchandise volume, capitalizing on a market previously underserved by traditional retail outlets.

Eiger BioPharmaceuticals

Debt Financing in 2016
Eiger BioPharmaceuticals is a late-stage biopharmaceutical company headquartered in Palo Alto, California, specializing in the development of targeted therapies for rare and ultra-rare diseases. The company's lead product candidate, Lonafarnib, is an orally bioavailable small molecule currently in Phase 3 clinical trials for the treatment of hepatitis delta virus (HDV) infection, a life-threatening condition with significant unmet medical needs. Eiger's pipeline also includes Lambda, which is being evaluated in Phase 2 trials for HDV treatment, and Lonafarnib is being explored for its potential use in treating progeria and progeroid laminopathies. Additionally, Avexitide, which has completed Phase 2 trials for post-bariatric hypoglycemia, is also undergoing clinical evaluation for congenital hyperinsulinism. Eiger's strategic focus is on efficient drug development to deliver safe and effective therapies to patients suffering from these serious conditions.

Potenza Therapeutics

Venture Round in 2016
Potenza Therapeutics, Inc. is a preclinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2014. The company focuses on developing a portfolio of oncology programs that harness the body's immune system to identify and eliminate tumors. Potenza's innovative approach is rooted in understanding the biological mechanisms by which cancer cells evade immune detection and destruction. By leveraging these insights, the company aims to create effective pharmaceuticals that enhance the health outcomes of cancer patients.

Bigstep

Seed Round in 2016
Bigstep is a cloud provider that specializes in making professional analytics solutions accessible to businesses of all sizes. Founded in 2013 by Lucas Roh, the company is headquartered in London and operates data infrastructure in the U.K. and Germany. Bigstep's platform features bare metal cloud technology, which is designed to optimize performance and reduce latency for demanding workloads. It offers a production-ready big data environment that can be set up quickly, along with scalable storage, high-speed networking, and enhanced security features. By utilizing advanced technologies and automation, Bigstep enables clients to achieve improved efficiency in both cost and performance.

TESARO

Post in 2016
Tesaro, Inc. is an oncology-focused biopharmaceutical company established in 2010 and headquartered in Waltham, Massachusetts. The company is dedicated to developing and commercializing cancer therapeutics and supportive care products. Its primary offerings include ZEJULA, a potent oral poly polymerase inhibitor for the maintenance treatment of recurrent ovarian, fallopian tube, or primary peritoneal cancer, and VARUBI, a neurokinin-1 receptor antagonist designed to prevent chemotherapy-induced nausea and vomiting. Additionally, Tesaro is engaged in the development of several immunotherapy antibody candidates, including TSR-042, TSR-022, and TSR-033, all currently in phase I clinical trials. The company collaborates with various organizations, such as AnaptysBio, Janssen Biotech, and Merck Sharp & Dohme, to enhance its research and development efforts. Tesaro aims to leverage its management team's expertise to identify and commercialize innovative treatments that improve the lives of cancer patients. As of January 2019, Tesaro operates as a subsidiary of GlaxoSmithKline.

Tizona Therapeutics

Series B in 2016
Tizona Therapeutics, Inc. is an immunotherapy company focused on developing treatments for cancer and autoimmune diseases. Founded in 2014 and located in South San Francisco, California, the company is known for its innovative products, including an Anti-CCR4 antibody aimed at cancer treatment, as well as IL-35 antagonists and agonists that target immune response modulation. Tizona is actively collaborating with its scientific founders to enhance understanding of the role of regulatory T cells in tumor immunosuppression, which is crucial for developing effective therapies. By targeting specific cell types and biological mechanisms responsible for immune suppression in the tumor microenvironment, Tizona aims to provide patients with durable and complete remissions from their conditions.

Aria Systems

Series E in 2016
Aria Systems provides a cloud-based monetization platform designed to assist subscription and usage-based businesses in effectively managing their revenue streams. The company offers an agile billing system that enables enterprises to capitalize on customer-driven events, referred to as revenue moments. By facilitating active customer engagement and the rapid development of new products and services, Aria's comprehensive platform allows global brands to enter the market more quickly and diversify their offerings. The platform also includes on-demand billing software, marketing intelligence tools, and customer lifecycle management services tailored for software-as-a-service (SaaS) companies, game developers, and telecommunications providers. Through these capabilities, Aria Systems aims to support long-term business growth and enhance customer satisfaction, retention, and lifetime value.

Stellar Loyalty

Series A in 2016
Stellar Loyalty Inc. specializes in providing cloud-based customer loyalty and engagement solutions. Founded in 2014 and headquartered in Foster City, California, with additional offices in Manila, Philippines, Stellar Loyalty integrates mobile and big data technologies to enhance customer interactions. The company’s platform enables brands to recognize, engage, and reward loyal customers by connecting loyalty programs with point-of-sale, marketing, and customer relationship management systems. Their offerings include advanced features such as calculations, business rules, segmentations, and predictive analytics, which together facilitate a seamless experience across digital, physical, and human interactions. Stellar Loyalty aims to enhance consumer experiences by delivering personalized value and recognition to customers. The company was acquired by Cheetah Digital in 2018.

Tizona Therapeutics

Series A in 2016
Tizona Therapeutics, Inc. is an immunotherapy company focused on developing treatments for cancer and autoimmune diseases. Founded in 2014 and located in South San Francisco, California, the company is known for its innovative products, including an Anti-CCR4 antibody aimed at cancer treatment, as well as IL-35 antagonists and agonists that target immune response modulation. Tizona is actively collaborating with its scientific founders to enhance understanding of the role of regulatory T cells in tumor immunosuppression, which is crucial for developing effective therapies. By targeting specific cell types and biological mechanisms responsible for immune suppression in the tumor microenvironment, Tizona aims to provide patients with durable and complete remissions from their conditions.

Benvenue Medical

Series F in 2016
Benvenue Medical, Inc. is a company specializing in the design, manufacture, and marketing of minimally invasive expandable implant systems for the treatment of spinal disorders, particularly vertebral compression fractures and degenerative disc diseases. Its key products include the Kiva treatment system, which addresses spinal fractures in the thoracic and lumbar regions, and the Blazer – C system, designed for pathological vertebral compression fractures. Additionally, the company offers the Luna 3D expandable interbody fusion system, suitable for various surgical approaches. Headquartered in Santa Clara, California, Benvenue Medical serves customers across the United States, Canada, Belgium, France, and Germany. Founded in 2004, the company is committed to providing innovative solutions that enhance patient outcomes and restore spinal alignment.

Crowdpac

Series A in 2016
Crowdpac, Inc. is a non-partisan political technology company based in Palo Alto, California, founded in 2013. It provides an online platform designed to enhance political participation by offering a comprehensive voting guide service. The platform consolidates disparate information about political candidates, including their funding sources, issue positions, voting behavior, and past activities, into easily accessible profiles. Users can explore candidates based on various issues such as healthcare, immigration, and education, allowing them to find and support those who align with their values. Additionally, Crowdpac is recognized as the first crowdfunding platform specifically for politics, empowering candidates, organizations, and citizens to fund political initiatives and campaigns independently of large donors. As of November 2019, Crowdpac operates as a subsidiary of Prytany.

Triposo

Venture Round in 2015
Triposo, Inc. specializes in developing interactive travel guides for mobile devices, offering users a range of resources including country maps, language guides, and detailed information about destinations. Founded in 2010 and headquartered in Amersfoort, the Netherlands, the company provides background information on culture and history, as well as recommendations for restaurants, bars, and activities such as hiking and biking. Triposo's mobile application utilizes an algorithm-based approach to present relevant travel options, drawing from open content sources like Wikitravel, Wikipedia, and OpenStreetMap. With a portfolio that includes 20 iOS guides and 50 Android guides, Triposo aims to enhance the travel experience by delivering curated and accessible information to travelers. As of October 2017, Triposo operates as a subsidiary of Musement S.r.l.

Celladon

Post in 2015
Celladon Corporation is a biotechnology company focused on developing molecular therapies for the treatment of heart failure. Founded in 2000 and headquartered in La Jolla, California, the company is known for its product candidates that address key enzyme deficiencies associated with advanced heart failure. One of its primary products, SERCA2a, is an enzyme that plays a crucial role in calcium cycling and contractility in heart muscle cells. Additionally, Celladon is developing MYDICAR, an enzyme replacement therapy aimed at improving heart function in patients suffering from heart failure.

Avedro

Series E in 2015
Avedro, Inc. is a medical device and pharmaceutical company specializing in the treatment of corneal disorders, particularly corneal ectatic conditions and refractive errors. The company has developed the Avedro Corneal Remodeling platform, which includes the KXL and Mosaic systems that utilize ultraviolet A (UVA) light, alongside a range of single-use riboflavin drug formulations. These technologies are primarily aimed at treating progressive keratoconus and corneal ectasia following refractive surgery. Avedro also focuses on advancing the science of Thermo-biomechanics, exemplified by its Keraflex procedure, a non-invasive method for corneal reshaping that preserves the cornea's biomechanical integrity. The company's products are marketed to ophthalmologists, hospitals, and ambulatory surgery centers in the United States and through international distributors. Avedro, originally established as ThermalVision, Inc. in 2002, is headquartered in Waltham, Massachusetts, and operates as a subsidiary of Glaukos Corporation.

Polymorph

Series A in 2015
Polymorph is a San Francisco-based company that offers a white-label software-as-a-service (SaaS) platform designed to enhance monetization for modern enterprises. Established in 2013, Polymorph provides a comprehensive ad serving stack, yield optimization tools, and APIs, enabling publishers to maximize revenue while minimizing costs. The platform allows for customizable and developer-friendly solutions that facilitate seamless integration of advertisements into websites and applications. By focusing on visually integrated ads that enhance user experience, Polymorph empowers publishers and media companies to manage diverse advertising placements across various digital channels effectively.

Welcome

Series D in 2015
Welcome is a marketing orchestration platform designed to enhance the efficiency and effectiveness of marketing teams. As a brand under NewsCred, it focuses on transforming marketing operations by aligning teams and streamlining execution processes. Welcome caters to the complexities of modern marketing, providing a scalable solution that supports large teams and integrates with various marketing technology tools. It enables marketers to collaborate more effectively, manage campaigns and content seamlessly, and demonstrate measurable results. By offering a comprehensive platform, Welcome empowers brands to maximize their marketing potential and achieve their strategic goals.

Wiser Solutions

Series A in 2015
Wiser Solutions is a leading provider of actionable data aimed at enhancing decision-making for brands and retailers. The company specializes in collecting and analyzing both online and in-store data with notable speed and precision. Its platform integrates insights from the retail sector with advanced workflow software, creating a comprehensive solution that serves various retail needs, including those of restaurants. By combining data science with human validation, Wiser offers a centralized approach to retail data analysis, enabling businesses to drive revenue, reduce costs, and improve marketing efficiency.

Mobee

Series A in 2015
Mobee operates a mobile crowd-sourcing platform that enables retailers and brand manufacturers to gather and analyze offline data related to shopper experiences. Through its mobile app, users are rewarded for providing insights by answering questions about their shopping experiences. This platform allows businesses to collect real-time data and photos, facilitating persona-based alerts and integration with existing workflows. By offering a more efficient and cost-effective alternative to traditional mystery shopping and merchandising services, Mobee helps retailers and brands make informed decisions to enhance customer experience and operational effectiveness.

Gynesonics

Venture Round in 2015
Gynesonics, Inc. is a medical device company that focuses on designing and developing minimally invasive solutions for symptomatic uterine fibroids in women. Established in 2005 and headquartered in Redwood City, California, with an additional location in Beuningen, the Netherlands, the company offers the Sonata System, which utilizes sonography-guided transcervical fibroid ablation for the treatment of fibroids under intrauterine sonography guidance. Gynesonics aims to provide a safe and effective incisionless alternative to traditional surgical techniques such as hysterectomy and myomectomy, thereby enabling women to receive painless treatments for severe menstrual symptoms associated with fibroids.

Realeve

Series D in 2015
Autonomic Technologies, Inc. is a medical device company that specializes in developing and commercializing innovative therapies for autonomic disorders, with a particular emphasis on severe headaches. Founded in 2007 and headquartered in Mountain View, California, the company has additional offices in Germany and Switzerland. Its flagship product, the ATI Neurostimulation System, is a miniaturized, battery-less microstimulator designed to deliver low-level energy directly to the sphenopalatine ganglion (SPG) to effectively treat chronic cluster headaches. This technology aims to set a new standard in the management of severe headaches and migraines, providing patients with a safe and effective treatment option.

Joyus

Series C in 2015
Joyus is a startup that offers an innovative online shopping experience centered around short-form videos. The company focuses on helping users discover and purchase products, primarily in the apparel, beauty, and lifestyle sectors, through engaging video content. Each week, Joyus features curated selections of items, showcasing how to utilize them effectively. This exclusive video sales platform allows customers to buy products for a limited time, making the shopping experience both dynamic and accessible. Joyus also emphasizes community engagement, enabling users to share their favorite videos easily on social media. By combining editorial content with direct-response video, the company provides a unique way for consumers to stay informed about the latest trends and gain expert advice, ultimately transforming the traditional shopping experience.

Realeve

Series D in 2015
Autonomic Technologies, Inc. is a medical device company that specializes in developing and commercializing innovative therapies for autonomic disorders, with a particular emphasis on severe headaches. Founded in 2007 and headquartered in Mountain View, California, the company has additional offices in Germany and Switzerland. Its flagship product, the ATI Neurostimulation System, is a miniaturized, battery-less microstimulator designed to deliver low-level energy directly to the sphenopalatine ganglion (SPG) to effectively treat chronic cluster headaches. This technology aims to set a new standard in the management of severe headaches and migraines, providing patients with a safe and effective treatment option.

The RealReal

Series D in 2015
The RealReal operates as the largest online marketplace for authenticated, resale luxury goods, specializing in various categories such as fashion for women, men, and children, as well as jewelry, watches, home items, and art. Founded in 2011 and headquartered in San Francisco, the company boasts over 37 million members and has sold nearly 40 million items through its platform. The RealReal employs a rigorous authentication process managed by in-house experts, including gemologists and horologists, ensuring the reliability of its offerings. As a sustainable business, it promotes the circular economy by giving new life to luxury items from numerous brands. The company simplifies the selling process for consignors with services such as virtual appointments, in-home pickups, and direct shipping, while managing all aspects of the transaction, from pricing and listing to shipping and customer service. In 2023, The RealReal generated significant gross merchandise volume, capitalizing on a market previously underserved by traditional retail outlets.

Aryaka Networks

Series C in 2015
Aryaka Networks, Inc. is a provider of cloud-based networking and security solutions, headquartered in San Mateo, California, with additional offices in Dallas, Bengaluru, Beijing, Singapore, London, and Toronto. Founded in 2008, the company specializes in software-defined wide area network (SD-WAN) services, offering a platform that integrates various networking needs, including WAN optimization, application acceleration, and security functions. Aryaka's services include WAN Optimization as-a-Service, which facilitates global connectivity and application performance, and SmartACCESS, a clientless SD-WAN solution for remote access. The company's offerings cater to enterprises and service providers worldwide, enabling improved connectivity for branch offices and cloud applications. Aryaka is recognized for its ability to modernize and optimize networking environments, ensuring that organizations can efficiently access centralized applications and public web resources regardless of location.

Pivot3

Series G in 2015
Pivot3, based in Palo Alto, is an IT company focused on simplifying data center operations by unifying storage, compute, and network resources into streamlined solutions. Founded with the goal of reducing cost, risk, and complexity, Pivot3 has developed technologies that have enabled thousands of enterprises globally to achieve their IT and business objectives. The company offers Dynamic Hyperconverged Infrastructure and PCIe Flash Arrays, which enhance resource utilization and ensure high availability for mission-critical applications. Pivot3's solutions deliver significant business benefits, including lower total cost of ownership, uninterrupted revenue generation, and improved customer satisfaction. With a diverse product portfolio optimized for various applications such as server virtualization, data center consolidation, and disaster recovery, Pivot3 has successfully deployed over 16,000 systems in 53 countries, serving a wide range of industries including energy, aerospace, logistics, and retail.

Invuity

Private Equity Round in 2015
Invuity, Inc. is a medical technology company based in San Francisco, California, focused on developing and marketing advanced surgical devices in the United States and Asia. Utilizing its intelligent photonics technology platform, Invuity creates both single-use and reusable illuminated surgical devices that enhance visualization during surgical procedures. The company's product lineup includes various illuminated retractors and handheld illuminators designed for a range of specialties, such as breast, orthopedic, gynecological, and spinal surgeries. Notable offerings include the Eikon LT illuminated retractor system, Eiberg illuminated retractors, and the PhotonBlade and PhotonSaber series, which provide targeted illumination to improve surgical outcomes. Invuity sells its devices through direct sales representatives, independent agents, and directly to hospitals and surgeons, as well as to third-party medical device manufacturers. Previously known as Spotlight Surgical, Inc., Invuity was founded in 2004 and operates as a subsidiary of Stryker Corporation.

Obalon Therapeutics

Series D in 2015
Obalon Therapeutics, Inc. is a medical device company based in Carlsbad, California, that specializes in developing and commercializing innovative solutions for obesity treatment. The company is known for its Obalon Balloon System, which includes a swallowable capsule containing an inflatable balloon, a navigation console for tracking balloon placement, a semi-automated inflation device, and a disposable gas canister. This system aims to assist patients in achieving weight loss through a non-surgical approach. Founded in 2008, Obalon emphasizes collaboration with clinicians and a commitment to rigorous testing to ensure safety and performance in its products. As of early 2020, the company operated three retail treatment centers in California, reflecting its focus on providing accessible solutions for individuals struggling with obesity.

Welltok

Series D in 2015
Welltok is a data-driven enterprise SaaS company based in Denver, Colorado, founded in 2009. It specializes in providing a consumer activation platform that serves the healthcare industry. Welltok’s solutions enable health plans, employers, providers, and public entities to engage consumers with personalized health improvement resources. The platform leverages a vast consumer database and machine learning to facilitate targeted actions, making it easier and more rewarding for individuals to optimize their health and wellbeing. By driving audience engagement in healthy activities, Welltok helps organizations connect with consumers on a personal level, enhancing their overall health outcomes.

Sera Prognostics

Series B in 2015
Sera Prognostics, Inc. is a biotechnology company based in Salt Lake City, Utah, focused on developing diagnostic tests that assess a woman's individual risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other pregnancy-related complications. Founded in 2008, Sera aims to improve maternal and neonatal health while addressing the significant economic and healthcare burdens associated with premature birth. The company's proprietary proteomics and bioinformatics platform underpins its pipeline of innovative diagnostic tests, including the PreTRM® Test, which provides physicians with critical information to identify women at higher risk for spontaneous premature delivery. By enabling earlier proactive interventions, Sera seeks to enhance pregnancy care and reduce healthcare delivery costs.

Knotch

Venture Round in 2015
Knotch, Inc. is an independent provider of real-time intelligence focused on digital marketing, headquartered in San Francisco, California. Established in 2012, the company addresses a key challenge faced by B2B and B2C marketers: the "missing middle" of the audience journey, which often results in guesswork and lost revenue. Knotch offers a comprehensive intelligence suite that allows brands to track the impact of their content across various stages of the audience journey. This platform provides crucial insights, metrics, and benchmarks, enabling marketing and media teams to effectively plan, measure, and optimize their content strategies across paid advertising channels. By delivering data-driven insights, Knotch helps marketers identify which content assets drive high-value actions and conversions, thereby enhancing overall marketing effectiveness.

Cuyana

Venture Round in 2015
Cuyana, Inc. is a San Francisco-based fashion brand that specializes in manufacturing and retailing clothing, bags, small leather goods, and accessories. Founded in 2011, the company fosters a philosophy of "fewer, better things," offering timeless apparel and accessories crafted from high-quality materials to ensure longevity. Cuyana operates an online platform and has physical showrooms in locations such as Palo Alto, New York City, Pacific Palisades, and Venice, Italy. By selling directly to consumers, Cuyana aims to make luxury fashion more accessible, bridging the gap between high-end goods and affordable options. The brand is recognized for its classic, modern aesthetic and commitment to quality, appealing to customers who value both style and sustainability.

InVisage Technologies

Series F in 2014
InVisage Technologies, Inc. is a fabless semiconductor company headquartered in Menlo Park, California, specializing in the development of QuantumFilm-based image sensors. Founded in 2005, the company focuses on producing advanced image sensors that capture high-fidelity and high-resolution images for various handheld devices, including camera phones and digital cameras. InVisage's technology is designed to absorb the full spectrum of light visible to the human eye, resulting in superior image quality. Its products have applications beyond mobile devices, extending to fields such as security and surveillance, automotive imaging, military, and medical imaging. As of November 2017, InVisage operates as a subsidiary of Apple Inc.

PMV Pharmaceuticals

Series A in 2014
PMV Pharmaceuticals, Inc. is a precision oncology company focused on the discovery and development of small molecule therapies targeting p53 mutations in cancer. Its lead candidate, PC14586, aims to correct and restore the function of the p53 protein, which is critical in regulating cell growth and preventing tumor formation. In addition to PC14586, the company is developing therapies for various p53 hotspot mutations, including the R273H mutation. Founded in 2013 and headquartered in Cranbury, New Jersey, PMV Pharmaceuticals leverages extensive expertise in p53 biology to advance its innovative treatment options for cancer patients.

Restoration Robotics

Series C in 2014
Restoration Robotics is a privately held medical device company focused on advancing hair transplantation technology. It has developed the ARTAS™ System, an innovative image-guided platform that facilitates follicular unit extraction, enhancing the precision and efficiency of hair restoration procedures. By integrating advanced imaging and robotics, Restoration Robotics aims to improve outcomes for patients seeking hair transplants, positioning itself as a leader in the evolving field of hair restoration. The company is committed to transforming traditional practices through its state-of-the-art technology.

Pivot3

Series E in 2014
Pivot3, based in Palo Alto, is an IT company focused on simplifying data center operations by unifying storage, compute, and network resources into streamlined solutions. Founded with the goal of reducing cost, risk, and complexity, Pivot3 has developed technologies that have enabled thousands of enterprises globally to achieve their IT and business objectives. The company offers Dynamic Hyperconverged Infrastructure and PCIe Flash Arrays, which enhance resource utilization and ensure high availability for mission-critical applications. Pivot3's solutions deliver significant business benefits, including lower total cost of ownership, uninterrupted revenue generation, and improved customer satisfaction. With a diverse product portfolio optimized for various applications such as server virtualization, data center consolidation, and disaster recovery, Pivot3 has successfully deployed over 16,000 systems in 53 countries, serving a wide range of industries including energy, aerospace, logistics, and retail.

Stellar Loyalty

Series A in 2014
Stellar Loyalty Inc. specializes in providing cloud-based customer loyalty and engagement solutions. Founded in 2014 and headquartered in Foster City, California, with additional offices in Manila, Philippines, Stellar Loyalty integrates mobile and big data technologies to enhance customer interactions. The company’s platform enables brands to recognize, engage, and reward loyal customers by connecting loyalty programs with point-of-sale, marketing, and customer relationship management systems. Their offerings include advanced features such as calculations, business rules, segmentations, and predictive analytics, which together facilitate a seamless experience across digital, physical, and human interactions. Stellar Loyalty aims to enhance consumer experiences by delivering personalized value and recognition to customers. The company was acquired by Cheetah Digital in 2018.

Braze

Series B in 2014
Braze, Inc. is a customer engagement platform that specializes in enhancing interactions between consumers and brands across various industries, including retail, media, financial services, and hospitality. Founded in 2011 and headquartered in New York, Braze provides a suite of mobile marketing automation and customer relationship management solutions. The platform integrates tools for engagement orchestration, campaign optimization, and cross-channel personalization, utilizing an AI engine called Sage AI to enhance functionality. Braze enables brands to create meaningful, context-driven conversations through various channels, ensuring relevant and timely interactions. The company has additional offices in Chicago, London, San Francisco, and Singapore, reflecting its global presence and commitment to delivering exceptional customer experiences. Formerly known as Appboy, Braze rebranded in November 2017 to better align with its mission of fostering human connections between consumers and the brands they love.

OPAL

Series A in 2014
Opal Labs Inc. is a marketing collaboration platform based in Portland, Oregon, founded in 2009. The company provides an online platform that enables organizations to effectively plan, create, view, edit, and approve their brand marketing content. By promoting alignment among marketing teams, Opal facilitates strategic campaign creation, streamlines the review process, and enhances content management, thereby reducing complexity and breaking down silos within organizations. The platform integrates seamlessly with various distribution methods, allowing teams to work together more efficiently and achieve successful marketing outcomes.

Pivot3

Series E in 2014
Pivot3, based in Palo Alto, is an IT company focused on simplifying data center operations by unifying storage, compute, and network resources into streamlined solutions. Founded with the goal of reducing cost, risk, and complexity, Pivot3 has developed technologies that have enabled thousands of enterprises globally to achieve their IT and business objectives. The company offers Dynamic Hyperconverged Infrastructure and PCIe Flash Arrays, which enhance resource utilization and ensure high availability for mission-critical applications. Pivot3's solutions deliver significant business benefits, including lower total cost of ownership, uninterrupted revenue generation, and improved customer satisfaction. With a diverse product portfolio optimized for various applications such as server virtualization, data center consolidation, and disaster recovery, Pivot3 has successfully deployed over 16,000 systems in 53 countries, serving a wide range of industries including energy, aerospace, logistics, and retail.

Splice Machine

Series B in 2014
Splice Machine, Inc. is a data platform company based in San Francisco, California, that develops a hybrid relational database management system (RDBMS) designed to seamlessly integrate streaming, analytics, and transactions. This platform leverages Apache Hadoop and Apache Spark to execute both operational and analytical workloads, allowing for real-time updates and the development of scalable applications without the need for application rewrites. Splice Machine's RDBMS is particularly beneficial for industries requiring digital marketing, ETL acceleration, operational data lakes, and Internet of Things applications. Additionally, the company offers Livewire, an open-source operational AI platform aimed at enhancing industrial IoT use cases by providing alerts to plant operators regarding outages or performance issues. Founded in 2012, Splice Machine aims to disrupt the traditional database market by enabling clients to reduce latency, costs, and complexity associated with legacy systems.

Gynesonics

Debt Financing in 2014
Gynesonics, Inc. is a medical device company that focuses on designing and developing minimally invasive solutions for symptomatic uterine fibroids in women. Established in 2005 and headquartered in Redwood City, California, with an additional location in Beuningen, the Netherlands, the company offers the Sonata System, which utilizes sonography-guided transcervical fibroid ablation for the treatment of fibroids under intrauterine sonography guidance. Gynesonics aims to provide a safe and effective incisionless alternative to traditional surgical techniques such as hysterectomy and myomectomy, thereby enabling women to receive painless treatments for severe menstrual symptoms associated with fibroids.

Cidara Therapeutics

Series A in 2014
Cidara Therapeutics is a biotechnology company based in San Diego, California, established in 2012. The company specializes in the discovery and development of innovative anti-infective therapies for serious diseases, particularly those that affect individuals with compromised immune systems. Its lead candidate, rezafungin acetate, is an antifungal agent designed to treat and prevent severe invasive fungal infections, such as candidemia and invasive candidiasis, which carry significant mortality risks. In addition to its antifungal efforts, Cidara is advancing its proprietary Cloudbreak platform, which focuses on developing antiviral Fc-conjugates aimed at preventing and treating various viral infections, including influenza, RSV, HIV, and coronavirus. Cidara's mission is to transform treatment and prevention strategies for life-threatening illnesses.

Benvenue Medical

Series E in 2014
Benvenue Medical, Inc. is a company specializing in the design, manufacture, and marketing of minimally invasive expandable implant systems for the treatment of spinal disorders, particularly vertebral compression fractures and degenerative disc diseases. Its key products include the Kiva treatment system, which addresses spinal fractures in the thoracic and lumbar regions, and the Blazer – C system, designed for pathological vertebral compression fractures. Additionally, the company offers the Luna 3D expandable interbody fusion system, suitable for various surgical approaches. Headquartered in Santa Clara, California, Benvenue Medical serves customers across the United States, Canada, Belgium, France, and Germany. Founded in 2004, the company is committed to providing innovative solutions that enhance patient outcomes and restore spinal alignment.

Victorious

Series A in 2014
Victorious is a search marketing platform focused on elevating search engine optimization (SEO) as a primary marketing channel rather than a supplementary tactic. Founded in 2013 and based in Santa Monica, California, Victorious develops long-term SEO campaigns that aim to generate compounding returns on investment for clients, ultimately supporting their overarching marketing strategies and business growth. The company offers a comprehensive suite of SEO services designed to enhance online visibility and drive substantial business outcomes. By prioritizing the best interests of both clients and team members, Victorious strives to redefine SEO's role in successful business development.

Aryaka Networks

Series C in 2014
Aryaka Networks, Inc. is a provider of cloud-based networking and security solutions, headquartered in San Mateo, California, with additional offices in Dallas, Bengaluru, Beijing, Singapore, London, and Toronto. Founded in 2008, the company specializes in software-defined wide area network (SD-WAN) services, offering a platform that integrates various networking needs, including WAN optimization, application acceleration, and security functions. Aryaka's services include WAN Optimization as-a-Service, which facilitates global connectivity and application performance, and SmartACCESS, a clientless SD-WAN solution for remote access. The company's offerings cater to enterprises and service providers worldwide, enabling improved connectivity for branch offices and cloud applications. Aryaka is recognized for its ability to modernize and optimize networking environments, ensuring that organizations can efficiently access centralized applications and public web resources regardless of location.

Apteligent

Series C in 2014
Apteligent, Inc. is a company that specializes in mobile application intelligence solutions, providing tools for real-time data collection and reporting. Its offerings include Userflows, which connect user experiences with business metrics, and a Crash Reporting solution that identifies and monitors application errors to mitigate user impact. Additionally, Apteligent provides Service Monitoring to analyze the performance of service and API metrics. The platform supports various mobile operating systems, including iOS, Android, Windows Phone, Hybrid, and HTML5 applications. Its solutions cater to businesses across multiple industries, including finance, retail, travel, media, and gaming. Formerly known as Crittercism, Apteligent was established in 2010 and is headquartered in San Francisco, California. As of 2017, the company operates as a subsidiary of VMware, Inc.

The RealReal

Series C in 2014
The RealReal operates as the largest online marketplace for authenticated, resale luxury goods, specializing in various categories such as fashion for women, men, and children, as well as jewelry, watches, home items, and art. Founded in 2011 and headquartered in San Francisco, the company boasts over 37 million members and has sold nearly 40 million items through its platform. The RealReal employs a rigorous authentication process managed by in-house experts, including gemologists and horologists, ensuring the reliability of its offerings. As a sustainable business, it promotes the circular economy by giving new life to luxury items from numerous brands. The company simplifies the selling process for consignors with services such as virtual appointments, in-home pickups, and direct shipping, while managing all aspects of the transaction, from pricing and listing to shipping and customer service. In 2023, The RealReal generated significant gross merchandise volume, capitalizing on a market previously underserved by traditional retail outlets.

Doximity

Series C in 2014
Doximity is a digital platform designed exclusively for medical professionals in the United States. With over 70% of U.S. physicians as members across various specialties and practice areas, Doximity offers a suite of tools tailored to enhance productivity and collaboration among healthcare providers. These tools enable doctors to communicate with colleagues, coordinate patient care securely, conduct virtual patient visits, stay informed about the latest medical news and research, and manage their careers effectively. The platform's mission is to support doctors in providing better healthcare by streamlining their professional activities.

Integrated Diagnostics

Series B in 2014
Integrated Diagnostics Inc. specializes in the development of laboratory-based blood molecular diagnostic tools designed to assist physicians in the early detection of complex diseases through non-invasive blood tests. The company's flagship product, Xpresys Lung, provides objective information for assessing pulmonary nodules by monitoring multiple disease molecular markers simultaneously. Founded in 2005 and based in Seattle, Washington, Integrated Diagnostics aims to leverage emerging technologies to create a pipeline of innovative diagnostic products that facilitate the management of serious conditions such as cancer, diabetes, and Alzheimer's. The company operates under the principle that a systems view of disease, involving networks of proteins, genes, and other molecules, is essential for effective diagnosis and prognosis. Integrated Diagnostics is a subsidiary of Biodesix, Inc. and has established a strategic partnership with Agilent Technologies.

Damballa

Series E in 2014
Damballa specializes in advanced threat protection, focusing on the detection of active threats that evade traditional security measures. The company employs innovative solutions that leverage data science and machine learning to identify successful infections and assess the risk posed by compromised devices, regardless of their type or operating system. Damballa's technology is designed to uncover threats without needing prior knowledge of their existence, making it effective across various threat vectors. The firm provides security for nearly a billion endpoints globally, serving enterprises across multiple sectors, as well as major internet service providers and telecommunications companies. By addressing issues such as botnet formation, Damballa plays a critical role in enhancing internet security and safeguarding businesses from evolving cyber threats.

InVisage Technologies

Series E in 2014
InVisage Technologies, Inc. is a fabless semiconductor company headquartered in Menlo Park, California, specializing in the development of QuantumFilm-based image sensors. Founded in 2005, the company focuses on producing advanced image sensors that capture high-fidelity and high-resolution images for various handheld devices, including camera phones and digital cameras. InVisage's technology is designed to absorb the full spectrum of light visible to the human eye, resulting in superior image quality. Its products have applications beyond mobile devices, extending to fields such as security and surveillance, automotive imaging, military, and medical imaging. As of November 2017, InVisage operates as a subsidiary of Apple Inc.

Polymorph

Seed Round in 2014
Polymorph is a San Francisco-based company that offers a white-label software-as-a-service (SaaS) platform designed to enhance monetization for modern enterprises. Established in 2013, Polymorph provides a comprehensive ad serving stack, yield optimization tools, and APIs, enabling publishers to maximize revenue while minimizing costs. The platform allows for customizable and developer-friendly solutions that facilitate seamless integration of advertisements into websites and applications. By focusing on visually integrated ads that enhance user experience, Polymorph empowers publishers and media companies to manage diverse advertising placements across various digital channels effectively.

DataRPM

Series A in 2014
DataRPM Corporation develops a cognitive data science platform that automates machine learning for enterprises, available both on the cloud and on-premises. This platform, known as the Cognitive Predictive Maintenance (CPdM) system, connects to data lakes and conducts multiple machine learning experiments to identify patterns, anomalies, and influencing factors in data. It builds predictive models to enhance predictive maintenance, particularly for the industrial Internet of Things. DataRPM serves a global clientele, including Fortune 500 companies, helping them digitally transform their operations in areas such as predictive maintenance, product recommendations, and churn predictions. Founded in 2011 and headquartered in Redwood City, California, the company also has offices in the United Kingdom and Bengaluru, India. DataRPM operates as a subsidiary of Progress Software Corporation, focusing on delivering a scalable platform that enables organizations to cultivate citizen data scientists and achieve a return on investment.

Grokker

Series A in 2014
Grokker Inc. is an online fitness training platform that offers a wide range of expert-led video content focused on wellness, including fitness, cooking, yoga, mindfulness, nutrition, finance, and sleep. Founded in 2012 and based in San Jose, California, Grokker provides users with access to over 3,700 videos varying in length from 5 to 50 minutes. The platform is designed to support workplace wellness by delivering personalized and easily implementable programs that promote employee health and fitness. Users can explore diverse categories, such as yoga styles, fitness routines, and various cooking techniques, while benefiting from a community that fosters connection among employees. Grokker's model emphasizes convenience, allowing access to its resources anytime and from any device, helping clients maintain a consistent routine for improved well-being.

Invuity

Series E in 2014
Invuity, Inc. is a medical technology company based in San Francisco, California, focused on developing and marketing advanced surgical devices in the United States and Asia. Utilizing its intelligent photonics technology platform, Invuity creates both single-use and reusable illuminated surgical devices that enhance visualization during surgical procedures. The company's product lineup includes various illuminated retractors and handheld illuminators designed for a range of specialties, such as breast, orthopedic, gynecological, and spinal surgeries. Notable offerings include the Eikon LT illuminated retractor system, Eiberg illuminated retractors, and the PhotonBlade and PhotonSaber series, which provide targeted illumination to improve surgical outcomes. Invuity sells its devices through direct sales representatives, independent agents, and directly to hospitals and surgeons, as well as to third-party medical device manufacturers. Previously known as Spotlight Surgical, Inc., Invuity was founded in 2004 and operates as a subsidiary of Stryker Corporation.

Welltok

Series C in 2014
Welltok is a data-driven enterprise SaaS company based in Denver, Colorado, founded in 2009. It specializes in providing a consumer activation platform that serves the healthcare industry. Welltok’s solutions enable health plans, employers, providers, and public entities to engage consumers with personalized health improvement resources. The platform leverages a vast consumer database and machine learning to facilitate targeted actions, making it easier and more rewarding for individuals to optimize their health and wellbeing. By driving audience engagement in healthy activities, Welltok helps organizations connect with consumers on a personal level, enhancing their overall health outcomes.

Totango

Series B in 2014
Totango, Inc. is a leading provider of a customer success platform designed to enhance customer engagement and drive business growth. Founded in 2010 and headquartered in Redwood City, California, the company specializes in customer-led growth by integrating customer data to monitor health changes and foster proactive engagement. Its suite of solutions includes the Customer Success Centre for customer engagement, Zoe for enterprise impact, and DNA-CX for real-time customer context. Additionally, Totango offers tools for customer onboarding, adoption, renewal, and risk management through its AI-powered Customer Intelligence Engine, Unison. The platform supports businesses in achieving predictable revenue and maximizing customer value by streamlining operations and providing actionable insights. Totango serves a diverse range of clients, including notable companies such as SAP and GitHub, and has established itself as an innovator in customer success technology. The organization has a remote workforce spanning multiple states and countries, with offices located in New York City and Tel Aviv.

Welcome

Series C in 2014
Welcome is a marketing orchestration platform designed to enhance the efficiency and effectiveness of marketing teams. As a brand under NewsCred, it focuses on transforming marketing operations by aligning teams and streamlining execution processes. Welcome caters to the complexities of modern marketing, providing a scalable solution that supports large teams and integrates with various marketing technology tools. It enables marketers to collaborate more effectively, manage campaigns and content seamlessly, and demonstrate measurable results. By offering a comprehensive platform, Welcome empowers brands to maximize their marketing potential and achieve their strategic goals.

Crowdpac

Seed Round in 2014
Crowdpac, Inc. is a non-partisan political technology company based in Palo Alto, California, founded in 2013. It provides an online platform designed to enhance political participation by offering a comprehensive voting guide service. The platform consolidates disparate information about political candidates, including their funding sources, issue positions, voting behavior, and past activities, into easily accessible profiles. Users can explore candidates based on various issues such as healthcare, immigration, and education, allowing them to find and support those who align with their values. Additionally, Crowdpac is recognized as the first crowdfunding platform specifically for politics, empowering candidates, organizations, and citizens to fund political initiatives and campaigns independently of large donors. As of November 2019, Crowdpac operates as a subsidiary of Prytany.

Khoros

Series D in 2014
Khoros is a software company specializing in customer engagement platforms. It offers a centralized cloud-based solution for social media management, enabling brands to monitor and scale their social marketing efforts and customer service interactions. The platform facilitates millions of conversations and drives informed decisions through data analysis, helping companies anticipate customer needs, accelerate sales, foster loyalty, and innovate by turning siloed knowledge into enterprise value and customers into contributors.

Khoros

Series D in 2014
Khoros is a software company specializing in customer engagement platforms. It offers a centralized cloud-based solution for social media management, enabling brands to monitor and scale their social marketing efforts and customer service interactions. The platform facilitates millions of conversations and drives informed decisions through data analysis, helping companies anticipate customer needs, accelerate sales, foster loyalty, and innovate by turning siloed knowledge into enterprise value and customers into contributors.

Flurry

Series D in 2013
Flurry, Inc. is a mobile application analytics and advertising platform that helps businesses build, measure, advertise, and monetize their mobile applications. Founded in 2005 and headquartered in San Francisco, Flurry offers a suite of products, including Flurry Analytics, which enables businesses to analyze consumer interactions across over 400,000 applications. The platform tracks more than 1 billion end-user sessions monthly and provides insights into audience reach, engagement, retention, and revenue. Flurry also offers solutions such as AppSpot, which serves targeted ads to enhance click-through rates and revenue, and Flurry Personas, which identifies consumer segments with shared interests. Additionally, Flurry Marketplace connects publishers with advertisers through a single SDK integration. With a user-friendly setup that takes just five minutes, Flurry's services are utilized by over 125,000 companies and are compatible with various mobile platforms, including iOS, Android, and Windows Phone.

Aria Systems

Series D in 2013
Aria Systems provides a cloud-based monetization platform designed to assist subscription and usage-based businesses in effectively managing their revenue streams. The company offers an agile billing system that enables enterprises to capitalize on customer-driven events, referred to as revenue moments. By facilitating active customer engagement and the rapid development of new products and services, Aria's comprehensive platform allows global brands to enter the market more quickly and diversify their offerings. The platform also includes on-demand billing software, marketing intelligence tools, and customer lifecycle management services tailored for software-as-a-service (SaaS) companies, game developers, and telecommunications providers. Through these capabilities, Aria Systems aims to support long-term business growth and enhance customer satisfaction, retention, and lifetime value.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.